Is polycystic kidney disease associated with malignancy in children?


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
07 2019
Historique:
received: 26 11 2018
revised: 18 03 2019
accepted: 08 04 2019
pubmed: 15 6 2019
medline: 19 6 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

Polycystic kidney disease (PKD) is an inherited condition characterized by progressive development of end-stage renal disease, hypertension, hepatic fibrosis, and cysts in the kidney, liver, pancreas, spleen, thyroid, and epididymis. While malignancies have been reported in association with PKD in adults, the incidence of malignancies in children with PKD is not currently known. We report on five patients with a known history of PKD who developed a malignancy as children at the University of California, Los Angeles and the University of Colorado Anschutz Medical Campus. Patients were included from 2012 to 2017. We present five patients with a history of PKD diagnosed with a malignancy during childhood without any additional known mutations to suggest a genetic predisposition to develop cancer. This includes the first reported case of hepatocellular carcinoma in a patient with autosomal recessive polycystic kidney disease. Our report illustrates the potential that PKD may be associated with an increased risk for developing cancer, even in children. Further research is necessary to better understand this relationship.

Sections du résumé

BACKGROUND
Polycystic kidney disease (PKD) is an inherited condition characterized by progressive development of end-stage renal disease, hypertension, hepatic fibrosis, and cysts in the kidney, liver, pancreas, spleen, thyroid, and epididymis. While malignancies have been reported in association with PKD in adults, the incidence of malignancies in children with PKD is not currently known.
METHODS
We report on five patients with a known history of PKD who developed a malignancy as children at the University of California, Los Angeles and the University of Colorado Anschutz Medical Campus. Patients were included from 2012 to 2017.
RESULTS
We present five patients with a history of PKD diagnosed with a malignancy during childhood without any additional known mutations to suggest a genetic predisposition to develop cancer. This includes the first reported case of hepatocellular carcinoma in a patient with autosomal recessive polycystic kidney disease.
CONCLUSION
Our report illustrates the potential that PKD may be associated with an increased risk for developing cancer, even in children. Further research is necessary to better understand this relationship.

Identifiants

pubmed: 31197971
doi: 10.1002/mgg3.725
pmc: PMC6625336
doi:

Substances chimiques

PKHD1 protein, human 0
Receptors, Cell Surface 0
TRPP Cation Channels 0
polycystic kidney disease 1 protein 0
polycystic kidney disease 2 protein 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00725

Informations de copyright

© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

Références

Pediatr Nephrol. 2017 Jan;32(1):31-42
pubmed: 27034070
J Endocrinol Invest. 2018 Jan;41(1):21-31
pubmed: 28589383
Nephron Clin Pract. 2013;123(1-2):13-21
pubmed: 23752029
Front Oncol. 2012 Apr 02;2:28
pubmed: 22649783
J Vasc Surg. 2005 Mar;41(3):539-43
pubmed: 15838492
Int J Cancer. 2013 Apr 1;132(7):1711-7
pubmed: 22927055
Lancet Oncol. 2016 Oct;17(10):1419-1425
pubmed: 27550645
Nat Rev Nephrol. 2015 Sep;11(9):515-34
pubmed: 25870008
Pediatrics. 2014 Sep;134(3):e833-45
pubmed: 25113295
Pediatr Blood Cancer. 2017 Jan;64(1):100-102
pubmed: 27577987
Nephrol Dial Transplant. 2001 Aug;16(8):1648-52
pubmed: 11477168
Neurol Clin. 2003 Nov;21(4):983-1004
pubmed: 14743661
J Am Soc Nephrol. 2014 Oct;25(10):2335-41
pubmed: 24854270
BMJ Case Rep. 2014 Dec 17;2014:
pubmed: 25519866
Nephrol Dial Transplant. 2012 Apr;27(4):1607-13
pubmed: 21873624
Mol Genet Genomic Med. 2019 Jul;7(7):e00725
pubmed: 31197971
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5466-71
pubmed: 16567633
J Cell Biol. 2010 Nov 15;191(4):701-10
pubmed: 21079243
Int J Cancer. 2015 Apr 1;136(7):1515-27
pubmed: 25123959
Exp Anim. 2012;61(5):477-88
pubmed: 23095811
Clin J Am Soc Nephrol. 2009 Dec;4(12):1998-2007
pubmed: 19875768
Pediatr Radiol. 2011 Nov;41(11):1465-8
pubmed: 21720858
J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):190-6
pubmed: 24806835
Adv Chronic Kidney Dis. 2011 Sep;18(5):339-47
pubmed: 21896375
PLoS One. 2018 Jan 16;13(1):e0190430
pubmed: 29338003
Pediatr Nephrol. 2014 Feb;29(2):223-34
pubmed: 24162162
Med Clin North Am. 2016 May;100(3):551-67
pubmed: 27095645

Auteurs

Brian D Friend (BD)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.
Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, California.

Kami Wolfe Schneider (K)

Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, Colorado.

Timothy Garrington (T)

Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, Colorado.

Laurel Truscott (L)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.

Julian A Martinez-Agosto (JA)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.
Department of Human Genetics, UCLA David Geffen School of Medicine, Los Angeles, California.
UCLA Clinical Genomics Center, Los Angeles, California.

Robert S Venick (RS)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.

Eileen Tsai Chambers (E)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.
Division of Pediatric Nephrology, Department of Pediatrics, Duke University, Durham, North Carolina.

Patricia Weng (P)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.

Douglas G Farmer (DG)

Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.

Vivian Y Chang (VY)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.
UCLA's Jonsson Comprehensive Cancer Center, Los Angeles, California.

Noah Federman (N)

Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.
UCLA's Jonsson Comprehensive Cancer Center, Los Angeles, California.
Department of Orthopaedics, UCLA David Geffen School of Medicine, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH